Should You Buy Clover Health Investments Corp (CLOV) Stock Thursday Morning?

Clover Health Investments Corp (CLOV) has fallen Thursday morning, with the stock decreasing -1.30% in pre-market trading to 3.03. CLOV's short-term technical score of 68 indicates that the stock has traded more bullishly over the last month than 68% of stocks on the market. In the Health Care Plans industry, which ranks 16 out of 146 industries, CLOV ranks higher than 27% of stocks. Clover Health Investments Corp has risen 23.29% over the past month, closing at $2.44 on July 14. During this period of time, the stock fell as low as $2.44 and as high as $3.55. CLOV has an average analyst recommendation of Buy. The company has an average price target of $3.50.

CLOV has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on CLOV!

See Full CLOV Report

Clover Health Investments Corp has a Long-Term Technical rank of 39. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 61% of the market scoring higher. In the Health Care Plans industry which is number 7 by this metric, CLOV ranks better than 7% of stocks.

Important Dates for Investors in CLOV:

-Clover Health Investments Corp is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-1.46. -We do not have a set dividend date for Clover Health Investments Corp at this time. Click Here To Get The Full Report on Clover Health Investments Corp (CLOV)